References
- Bjornsson T, Callaghan J, Einof H, Fischer V, Gan L, Grimm S, Kao J, King P, Miwa G, Ni L, Kumar G, McLeod J, Obach S, Roberts S, Roe A, Shah A, Snikeris F, Sullivan J, Tweedie D, Vega J, Walsh J, Wrighton S. (2003). The conduct of in vitro and in vivo drug–drug interaction studies: a PhRMA perspective. J Clin Pharmacol 43:443–69.
- Carr B, Norcross R, Fang Y, Lu P, Rodrigues D, Shou M, Rushmore T, Booth-Genthe C. (2006). Characterization of the rhesus monkey CYP3A64 enzyme: Species comparisons of CYP3A substrate specificity and kinetics using baculovirus-expressed recombinant enzymes. Drug Metabol Disposit 34:1703–12.
- Igarashi T, Sakuma T, Isogai M, Nagata R, Kamataki T. (1997). Marmoset liver cytochrome P450s: study for expression and molecular cloning of their cDNSs. Arch Biochem Biophys 339:85–91.
- Komori M, Kikichi O, Kitada M, Kamataki T. (1992a). Molecular cloning of monkey 1A1 cDNA and expression in yeast. Biochim Biophys Acta 1131:23–9.
- Komori M, Kikuchi O, Sakuma T, Funaki J, Kitada M, Kamataki T. (1992b). Molecular cloning of monkey liver cytochrome P-450 cDNAs: similarity of the primary sequences to human cytochrome P-450. Biochim Biophys Acta 1171:141–6.
- Lee A, Yue J, Tyndale R. (2006). In vivo and in vitro characterization of chlorzoxazone metabolism and hepatic CYP2E1 levels in African green monkeys: Induction by chronic nicotine treatment. Drug Metabol Disposit 34: 1508–15.
- Mankowski D, Laddison K, Christopherson P, Ekins S, Tweedie D, Lawton M. (1999). Molecular cloning, expression, and characterization of CYP2D17 from cynomolgus monkey liver. Arch Biochem Biophys 372:189–96.
- Mitsuda M, Iwasaki M, Asahi S. (2002). Cynomolgus monkey cytochrome P450 2C43: cDNA cloning, heterologous expression, purification and characterization. J Biochem 139:865–72.
- Nelson D, Zeldin D, Hoffman S, Maltais, L, Wain H, Nebert D. (2004). Comparison of cytochrome (CYP) genes from the mouse and human genomes, including nomenclature recommendations for genes, pseudogenes and alternative-splice variants. Pharmacogenetics 14:1–18.
- Sakuma T, Hieda M, Igarashi T, Ohgiya S, Nagata R, Nemoto N, Kamataki T. (1998). Molecular cloning and functional analysis of cynomolgus monkey CYP1A. Biochem Pharmacol 56:131–9.
- Sharer J, Shipley L, Vandenbranden M, Binkley S, Wrighton S. (1995). Comparisons of phase I and phase II in vitro hepatic enzyme activities of human, dog, rhesus monkey, and cynomolgus monkey. Drug Metabol Disposit 23: 1231–42.
- Uno Y, Fujino H, Kito G, Kamataki T, Nagata R. (2006). CYP2C76, a novel cytochrome P450 in cynomolgus monkey, is a major CYP2C in liver, metabolizing tolubutamide and testosterone. Mol Pharmacol 70:477–86.
- Uno Y, Hosaka S, Matsuno K, Nakamura C, Kito G, Kamataki T, Nagata R. (2007a). Characterization of cynomolgus monkey cytochrome P450 (CYP) cDNAs: Is CYP2C76 the only monkey-specific CYP gene responsible for species differences in drug metabolism? Arch Biochem Biophys 466:98–105.
- Uno Y, Kumano T, Kito G, Nagata R, Kamataki T, Fujino H. (2007b). CYP2C76-mediated species difference in drug metabolism: a comparison of pitavastatin metabolism between monkeys and humans. Xenobiotica 37:30–43.